| DAVITA INC. DL -,001 |
| USA |
| Gesundheit |
| US23918K1088 / 897914 |
| TRL (Frankfurt) / DVA (NYSE) |
| FRA:TRL, ETR:TRL, TRL:GR, NYSE:DVA |
| S&P500 |
| https://www.davita.com/ |
|
DaVita Inc. is a healthcare services company specializing in kidney care, with a primary focus on providing dialysis treatments for patients with chronic kidney failure and end-stage renal disease. The company operates a large network of outpatient d..
>Volltext.. |
| 13010.2 Mio. EUR |
| 25342.18 Mio. EUR |
| 11998.01 Mio. EUR |
| 2400.07 Mio. EUR |
| 655.98 Mio. EUR |
| 9.23 EUR |
| 11465.33 Mio. EUR |
| 629.95 Mio. EUR |
| 1758.42 Mio. EUR |
| 0.26 |
| -0.11% |
| -17.6% |
| - |
| - |
| - |
| 1 Insider verkaufte innerhalb der letzten 30 Tage Aktien im Wert von 31.641.184 Euro. |
| DAVITA |
| 05.08.26 |
|
||||
|
||||
|
||||
|